{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"EP Edge Journal Watch: Cardiac Electrophysiology Research","title":"LAAO vs Anticoagulation Explained: WATCHMAN FLX, AF Ablation Recurrence, Post-TAVR Heart Block & ICU AF, Hormones and TdP – EP Edge Journal Watch","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/29bb14cf\"></iframe>","width":"100%","height":180,"duration":856,"description":"EP Edge Journal Watch Podcast — Issue 6 (January 2026)\nLeft Atrial Appendage Occlusion, AF Ablation Insights, Post-TAVR Conduction, ICU Anticoagulation & Translational EP Signals\nEP Edge Journal Watch is your high-yield, evidence-driven electrophysiology podcast—designed for busy clinicians who want clinical relevance, mechanistic insight, and practice-changing nuance without wading through every paper.\nIn Issue 6 (January 2026), we anchor the episode around Left Atrial Appendage Occlusion (LAAO)—examining long-term randomized outcomes, implant mechanics that truly matter, and frontier strategies for the most complex patients—then expand into essential EP topics you’ll actually use on rounds.\n\nWhat’s covered in this episode?\n1.      LAAO vs Oral Anticoagulation — Long-Term Outcomes\nWe break down a contemporary randomized trial meta-analysis (including OPTION) examining:\nStroke and systemic embolism\nHemorrhagic vs non-procedural bleeding\nA provocative mortality signal favoring LAAO\n Practical implications for counseling ablation patients and high-bleeding-risk populations.\n2.      WATCHMAN FLX Mechanics — Why Compression Matters\nA deep dive into device sizing and compression:\nOver-compression thresholds\nImpact on peridevice leak (PDL)\nHow this data should influence real-world implant decisions.\n3.      Persistent LAA Thrombus — Is There a Salvage Path?\nWe discuss a multicenter experience using:\nPercutaneous aspiration thrombectomy\nEmbolic protection strategies\nSame-session, no-touch LAA closure\n A feasibility signal—not for routine practice, but critical for expert centers facing clinical dead-ends.\nOPTION Sub-Analysis — Does LAAO Worsen AF Recurrence?\nUsing the largest randomized dataset available:\nConcomitant vs staged LAAO with ablation\nAF recurrence, cardioversion, redo ablation\nWhy “no AF recurrence” ≠ “no stroke risk”.\n4.      Post-TAVR Conduction Disturbances\nA physiology-forward look at:\nIntraprocedural vs delayed high-grade AV block\nHV interval and PR...","thumbnail_url":"https://img.transistorcdn.com/C7iPWVsHlGRm13syn3X4eXGLcqOXyzcuH5XmVutqgHc/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jMzFi/ZTYxOTI1M2U4NGRj/OGZmZjBhMDFlMjFm/NDQwMC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}